1. Breast Anatomic sites and subsites of the breast. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

2. Breast Schematic diagram of the breast and regional lymph nodes. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

3. Breast Tis (Paget's) is defined as Paget's disease of the nipple with no tumor. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

4. Breast T1mi is defined as microinvasion 1 mm or less in greatest dimension. The presence of multiple tumor foci of microinvasion (top of diagram) should be noted in parentheses. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

5. Breast T1 is defined as a tumor 20 mm or less in greatest dimension. T1a is defined as tumor more than 1 mm but not more than 5 mm in greatest dimension; T1b is defined as tumor more than 5 mm but not more than 10 mm in greatest dimension; T1c is defined as tumor more than 10 mm but not more than 20 mm in greatest dimension. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

6. Breast T2 (above dotted line) is defined as tumor more than 20 mm but not more than 50 mm in greatest dimension, and T3 (below dotted line) is defined as tumor more than 50 mm in greatest dimension. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

7. Breast T4 is defined as a tumor of any size with direct extension to chest wall and/or to the skin (ulceration or skin nodules). T4a (illustrated here) is extension to the chest wall, not including only pectoralis muscle adherence/invasion. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

8. Breast T4b, illustrated here as satellite skin nodules, is defined as edema (including peau d’orange) of the skin, or ulceration of the skin of the breast, or satellite skin nodules confined to the same breast. These do not meet the criteria for inflammatory carcinoma. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

9. Breast T4b illustrated here as edema (including peau d’orange) of the skin. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

10. Breast T4c is defined as both T4a and T4b. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

11. Breast T4d is inflammatory carcinoma. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

12. Breast N1 is defined as metastasis in movable ipsilateral level I, II axillary lymph node(s). Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

13. Breast N2a is defined as metastasis in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

14. Breast N2b is defined as metastasis only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastasis. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

15. Breast N3a is defined as metastasis in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

16. Breast N3b is defined as metastasis in clinically detected ipsilateral internal mammary lymph node(s) and clinically evident axillary lymph node(s). Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

17. Breast N3c is defined as metastasis in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

18. Breast pN0(i + ) is defined as malignant cells in regional lymph node(s) no greater than 0.2 mm (detected by H&E or IHC including ITC). Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

19. Breast Illustrated definition of pN1mi, defined as micrometastasis greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm. Also illustrated are pN1a defined as metastases in 1-3 axillary lymph nodes, at least one metastasis greater than 2.0 mm; pN2a defined as metastases in 4-9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm); and pN3a defined as metastases in ten or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm). Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

20. Breast pN1b metastases in internal mammary nodes detected by sentinel lymph node biopsy but not clinically detected. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

21. Breast pN1c illustrating 3 positive axillary lymph nodes and metastases in internal mammary lymph nodes detected by sentinel lymph node biopsy but not clinically detected. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

22. Breast pN2b illustrating metastases in clinically detected internal mammary nodes with no axillary lymph node involvement. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

23. Breast pN3b illustrated as metastases in clinically detected internal mammary nodes in the presence of 3 positive axillary lymph nodes. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

24. Breast pN3b illustrated as metastases in 6 positive axillary lymph nodes and in one internal mammary lymph node with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer

25. Breast pN3c illustrated as metastases in ipsilateral supraclavicular lymph nodes. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer